Large cohort study confirms link between pioglitazone, bladder cancer
Pioglitazone was linked to a 63% increase in bladder cancer risk, compared with other noninsulin antidiabetic drugs in a large population-based cohort study.
Furthermore, incidence rose the longer...
Source: Family Practice News - Category: Primary Care Source Type: news
More News: Actos | Bladder Cancer | Cancer | Cancer & Oncology | Family Practices | Primary Care | Study